Co-founder, ophthalmologist, and clinician-scientist with recognised expertise in glaucoma and visual field assessment. George provides clinical governance and evidence oversight, ensuring alignment with clinical standards, regulatory expectations, and real-world practice requirements.

Co-founder and internationally recognised vision scientist specialising in perimetry and visual neuroscience. Algis led the original development of the Melbourne Rapid Fields technology and continues to oversee technical performance, algorithms, and ongoing validation.

Board Director with extensive experience in healthcare commercial strategy, partnerships, and market entry. Mo provides governance oversight and commercial guidance, contributing to pricing strategy, distribution models, and partner engagement to support scalable adoption of the Melbourne Rapid Fields platform.

Anabela brings deep experience commercialising regulated health technologies across diagnostics, medtech, and digital health, with a track record spanning clinical validation, regulatory strategy, capital raising, and go-to-market execution across Australia and international markets.